Louis Garguilo

ARTICLES BY LOUIS

  • From CMO To CMO: A Biopharma With All The Right Moves
    From CMO To CMO: A Biopharma With All The Right Moves

    There’s a quotidian calculation to outsourcing at Allena Pharmaceuticals that's well worth studying.

    “As a small biotech, we could get kicked to the curb because somebody else has more dollars, and can occupy longer those assets at a CMO that we need. Because of this, we’ve evolved a concept of portability for our manufacturing process that may be anathema to a lot of companies …"

  • Japan Pharma: Top Tier With Tons Of Opportunity
    Japan Pharma: Top Tier With Tons Of Opportunity

    Opportunities related to the world’s third largest pharma industry tend to get drowned out by U.S. domestic events, and news from Europe, China, and even India. But if you haven’t been, it’s time to start paying attention to Japan again. There are opportunities for partnering, providing services to Japan Pharma, and for market penetration by foreign biopharma companies.

  • Biopharma’s Technology Scouts: Time To Look At CDMOs, Too?
    Biopharma’s Technology Scouts: Time To Look At CDMOs, Too?

    We’ve heard stories where service providers bring ideas for innovations to biopharma clients, but get rebuked because of the immediate focus on the bottom line for services. Perhaps sponsors should make a new comparison: Where is innovative, biopharma-applicable new-tech, perhaps already focused on elements of a drug owner’s pipeline, actually cheaper to come by? 

  • Hospitals To Serve Up IVs, And Now APIs?
    Hospitals To Serve Up IVs, And Now APIs?

    Outsourced Pharma readers must be scratching your heads over the mass-media reported news splash that Intermountain Healthcare is leading four U.S.-based “health care systems” in a consortium to form a generic drug company. In other words, hospitals are getting into APIs. And this, we are told, will save the world from shortages, while reducing pricing for generic drugs. Let’s just say some questions remain, such as: “How’s that all going to work?” 

  • No Prescription For Fake News
    No Prescription For Fake News

    We could never get away with “fake news” here. You’d run us out of town in a New York minute. But here’s some thoughts and historical perspective on this theme swirling around us today.

  • Innovation Envy: Surfing California For Next Biopharma Wave
    Innovation Envy: Surfing California For Next Biopharma Wave

    If you’re interested in new tech and innovation – including outside of the biopharma space – and enjoy warm weather and coastlines, you won’t help but envy Ravi Kiron. Merck KGaA has given him the job of all jobs. Kiron has became the head of biopharma external innovation at Merck’s EMD Serono, Inc., and tasked with establishing its Silicon Valley Innovation Hub. Try not to be too jealous of Kiron as you’re reading. More jobs like his may be on the way. 

  • Biopharma Experts Are Consistent: Expect More Cells, And Outsourcing
    Biopharma Experts Are Consistent: Expect More Cells, And Outsourcing

    When queried about the areas of most importance to them, their companies, and the biopharma outsourcing industry over the next 12 months, experienced professionals from around the world came back with this: cells, cells, and more cells.

  • Our 2018 Outsourcing Outlook: Focus On … Amazon?
    Our 2018 Outsourcing Outlook: Focus On … Amazon?

    It’s time for our 2018 industry outlook. But don’t worry if you’ve already had your share of forecasts slipped into your stockings. I promise ours brings something different to the prognostication party. And it should help readers to consider carefully what you need to focus on to make it another successful year.

  • Most Of What I Know About CMC I Learned At A CDMO
    Most Of What I Know About CMC I Learned At A CDMO

    How does the modern-day CMC leader at drug sponsors get the job done? Michael Markey, newly appointed CMC Director, Pharmaceutical Sciences, Radius Health, Inc., says applying past experiences from working at CDMOs helps. However, there’s a lesson he’s learned since joining Radius, and it has to do with branding and the marketing of contract services.

  • The Future Of CMC Leadership At Radius Health
    The Future Of CMC Leadership At Radius Health

    New CMC leader — and former colleague — Mike Markey says, “What’s most important to remember about a virtual company is all of our functions work at a desk. None of us actually have hands on; we rely on our CMO partners to get the work done. For me, the external project managers become an integral part of my day-to-day work.”

Louis Garguilo

Louis Garguilo



Louis Garguilo is chief editor and conference chair for Outsourced Pharma, and a contributing editor to Life Science Leader magazine. He studied public relations and journalism at Syracuse University (and holds a Master’s in English), and has 30+ years of international experience in business communications and development positions. Louis spent a decade at a global pharmaceutical contract research, development and manufacturing organization; served under the governor of New York in the state’s economic development agency, as liaison to the pharmaceutical/biotechnology industry; was chief strategic officer for an e-learning software company; and spent most of the ‘80s and ‘90s in Japan as an educator, author, and business communications consultant, including for the Osaka Medical Center for Cancer and Cardiovascular Diseases.